Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Nasopharyngeal Carcinoma 6Colorectal Neoplasms 4Lung Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Nasopharyngeal Neoplasms 2Head and Neck Neoplasms 2Squamous Non-small Cell Lung Cancer 1Sarcoma 1Recurrence 1Neuroblastoma 1Meningeal Carcinomatosis 1Melanoma 1Lymphoma, T-Cell 1Locally Advanced Squamous Non-small Cell Lung Cancer 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Breast Cancer Organoids 1Advanced Pancreatic Cancer 1Adenoviridae Infections 1Adenocarcinoma of Lung 1

Interventions

Endostatins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Locally Advanced Squamous Non-small Cell Lung Cancer × Endostatins × Clear all
NCT06279754 2024-02-28

Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

The First Affiliated Hospital of Xinxiang Medical College

Phase 2 Unknown
30 enrolled
Thoracic

Locally Advanced Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡